Product Information

PITAVASTATIN 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9565 per EA under NDC 65862081490. Its NADAC has been published 144 times since Feb 21, 2024.

FDA first approved this application on Dec 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PITAVASTATIN 4 MG TABLET

Pitavastatin
$0.9565per EA

Strength

4 mg/1

NDC

65862081490

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206015

FDA Approved

12/20/2016

TE Code

AB

On Market Since

11/2/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 4 MG TABLET has been published 144 times since Feb 21, 2024, and over the history we have for it it has declined 59.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9565 per EA
All-time high$2.3451 (Mar 13, 2024)
All-time low$0.9565 (Nov 18, 2026)
52-week high$1.5488
52-week low$0.9565
Median price$1.5480
Average price$1.5654
Largest weekly change+24.9% (Aug 21, 2024)
Weeks tracked144
Tracking sinceFeb 21, 2024

Price History

1W

-3.3%

1M

-7.1%

3M

-15.8%

6M

-27.7%

1Y

-38.2%

3Y

N/A

5Y

N/A

All

-59.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.9565 per EA (NDC 65862081490), effective Nov 18, 2026.

How has the price of PITAVASTATIN 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 59.2%. It has been tracked across 144 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?

Since Feb 21, 2024, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $0.9565 (Nov 18, 2026) to a high of $2.3451 (Mar 13, 2024), with a median of $1.5480 per EA.

Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 4 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PITAVASTATIN 4 MG TABLET?

PITAVASTATIN 4 MG TABLET (NDC 65862081490) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.